Vitamin B6 and Unisom for Morning Sickness

No, you don't have to take them together. The American College of Obstetricians and Gynecologists (ACOG) says vitamin B6 can be tried first for morning sickness, and doxylamine, the sleep-aid ingredient in Unisom SleepTabs, can be added if B6 alone doesn't help¹.

Talk to your prenatal provider before starting either one. In ACOG's guidance, these medicines come in when diet and lifestyle changes don't help or symptoms are severe, once your provider has ruled out other causes¹. ACOG's B6 dose is 10-25 mg three or four times a day². If you add Unisom, it should be the doxylamine version (SleepTabs), not a diphenhydramine one³, on a schedule your provider sets. The pair's benefit over placebo is modest. This page covers vitamin B6 in pregnancy; the nausea page covers other causes.

No. Vitamin B6 (pyridoxine) can be used on its own, and ACOG puts it first¹. Doxylamine is the add-on for women whose nausea continues¹. The pairing exists because the prescription pill for morning sickness combines the two, and a 2014 review called it the only medicine the US Food and Drug Administration (FDA) had approved for the condition⁴.

B6 alone has trial support. In a trial of 342 women up to 17 weeks pregnant, 30 mg of pyridoxine a day reduced nausea scores more than placebo over 5 days, though the drop in vomiting episodes missed statistical significance⁵. A 2023 meta-analysis of 18 studies found pyridoxine, alone or combined with another active ingredient, improved nausea scores⁶.

Is the combination better than B6 alone? Only weakly shown. A Canadian review concluded that evidence the combination beats pyridoxine alone is limited, and that B6 alone has stronger support for safety in pregnancy⁷. A matched cohort of 160 women found the combination improved symptom scores more after a week, especially in women with severe symptoms (2.6 points versus 0.4)⁸. Cohort data can't prove cause, so treat that as a hint rather than a verdict.

Unisom SleepTabs contain 25 mg of doxylamine⁹. Unisom's other sleep aids, including SleepGels, contain diphenhydramine, the ingredient in Benadryl^{3, 4}. The morning-sickness pairing uses doxylamine. The trials behind it tested doxylamine with pyridoxine, so check the active ingredient on the box, not the brand name^{10, 11}.

Diphenhydramine is also an H1 antihistamine, and the 2024 UK guideline lists antihistamines as first-line options for nausea and vomiting in pregnancy¹². A 2014 review says other antihistamines, including diphenhydramine, can replace doxylamine when B6 with doxylamine isn't enough, and that replacing it rather than adding a second one is preferred, to limit drowsiness⁴. So don't take a diphenhydramine product on top of doxylamine, and make any switch with your prenatal provider.

ACOG recommends 10-25 mg of B6 three or four times a day, adding doxylamine if symptoms don't improve². A 2014 review sets out the doses, including ACOG's treatment steps⁴:

• B6 alone (ACOG): 10-25 mg, three or four times a day.
• Adding doxylamine (ACOG): 12.5 mg, three or four times a day, with the schedule adjusted to how severe symptoms are. Half of a scored 25 mg Unisom SleepTabs tablet gives 12.5 mg^{4, 9}.
• Prescription pill (10 mg doxylamine and 10 mg B6, delayed release): two tablets at bedtime, adding one in the morning, then one in the afternoon, up to four a day⁴.

ACOG's steps assume your provider has ruled out other causes of nausea and vomiting⁴. The Unisom box says one tablet at bedtime, once a day, unless a doctor directs otherwise⁹, so daytime half-tablets for morning sickness should follow your prenatal provider's plan, not your own. Trial doses fall in the same range: 25 mg of B6 every 8 hours for 72 hours in a 59-woman trial¹³.

When to take it

The prescription tablets are delayed-release: the bedtime dose is timed to start working in the early morning, when symptoms usually peak⁴. The prescription label says to take them on an empty stomach with a glass of water, swallow them whole, and take them daily rather than only when you feel sick¹⁴. Over-the-counter B6 and Unisom tablets are not delayed-release⁴.

Starting early may help women who had severe symptoms before. In a 60-woman trial of women who had severe nausea and vomiting in a previous pregnancy, starting the prescription combination before symptoms began led to fewer moderate-to-severe cases than starting it once symptoms appeared (15.4% versus 39.1%)^{15, 16}. That's a single small trial, so ask your provider whether it fits your situation.

How long can you take it?

The trials we read ran from 3 to 14 days^{13, 10}, so they can't say how long continued use is ideal. The prescription label says your provider should reassess whether you still need it as pregnancy goes on¹⁴. For most women, nausea and vomiting of pregnancy is gone by 14 weeks, though for some it lasts longer¹.

100 mg a day is the US tolerable upper intake level for adults, including pregnant women aged 19 and over; it is 80 mg for ages 14-18². The limit exists because very high B6 intake can cause severe sensory neuropathy, skin lesions and photosensitivity². It doesn't apply to people taking B6 as a medical treatment, but they should be under a physician's care, and the NIH advises pregnant women to consult a physician before taking B6 supplements because doses could approach the limit².

Europe's food safety agency sets a far lower limit. In 2023 the European Food Safety Authority set an upper limit of 12 mg a day for all adults, including pregnant women, based on systematic reviews of B6 and nerve damage². ACOG's morning-sickness doses are well above that, so take them as a medical treatment agreed with your provider, not as a routine supplement.

Do the arithmetic before you start. Four 25 mg doses reach the US ceiling of 100 mg, and 200 mg a day is double it². The doses in trials were lower: 30 mg a day in one⁵, 75 mg a day in another¹³. Count B6 from every product you take, including a prenatal vitamin or a combination pill, toward the same limit.

It works a little. In a 2010 randomized trial of 256 women (7-14 weeks pregnant), the delayed-release doxylamine-B6 pill improved the Pregnancy-Unique Quantification of Emesis (PUQE) score by 4.8 points versus 3.9 for placebo over 14 days (P = 0.006)^{10, 17}. A reanalysis of the same trial found the gap was 0.73 points with one method of handling missing data, not statistically significant with others, and below the trial's own 3-point threshold for a clinically important benefit¹⁷.

A 2023 trial in 352 women with moderate-to-severe symptoms found a 1.0-point larger PUQE drop with doxylamine-B6 than placebo over 14 days, and the authors called the clinical importance uncertain¹⁸.

Reviews agree the evidence is thin. A Cochrane review of 41 trials in 5,449 women found only limited evidence for B6, doxylamine-pyridoxine and other drugs for mild or moderate symptoms¹⁹. A broader 2016 review of 78 studies found B6, antihistamines and doxylamine-pyridoxine were each associated with better symptoms than placebo, but rated the overall quality of evidence as low¹⁶. Both can be true: the benefit looks small, and the evidence behind it is weak.

For related evidence pages, see pregnancy support and the fertility and pregnancy topic.

The safety record is long but not spotless. Meta-analyses of the original combination drug (Bendectin) found no increase in malformations, with a relative risk of 0.95 for any malformation⁴. A 2017 meta-analysis of 37 studies found H1 antihistamines as a class were not linked to more major malformations (odds ratio 1.07, 95% confidence interval 0.98-1.16)²⁰.

A 2019 Quebec cohort of 45,623 exposed pregnancies reported slightly higher odds of major malformations with doxylamine-B6 (adjusted odds ratio 1.07), and of spina bifida (1.87)²¹. A later meta-analysis found no overall rise (odds ratio 1.02), a possible rise in central nervous system defects (1.25), and argued that exposure and outcome misclassification could explain that signal²². In the 2023 trial, babies of women on doxylamine-B6 were more often small for gestational age (odds ratio 3.8, 95% confidence interval 1.0 to 14.1), a wide interval that makes the estimate imprecise¹⁸.

Taken together, guidelines still support the pair: the 2024 UK guideline lists doxylamine-pyridoxine as a first-line option¹², and ACOG describes it as an add-on to B6¹. But B6 alone has the stronger safety support⁷, so weigh the combination with your provider rather than treating it as risk-free.

Drowsiness

Doxylamine is a sedating antihistamine sold as a sleep aid, with a half-life of 10-12 hours, so it can cause next-day drowsiness³. Sleepiness was the most common side effect of the prescription pill in its 15-day trial: 14.3% of women versus 11.7% on placebo¹⁴. Headache, dizziness and dry mouth have also been reported⁴. Don't drive or operate heavy machinery until your provider says it's safe¹⁴; the Unisom label says not to drive or operate machinery while using it⁹.

What not to mix it with

The prescription label says doxylamine-B6 is not recommended with alcohol or other drugs that depress the central nervous system, because the mix can cause severe drowsiness leading to falls or accidents¹⁴. A 2014 review lists sedating medicines to avoid with it, including other antihistamines (which may be in cough and cold medicines), opiates and sleep aids⁴. Don't take Unisom SleepTabs with the prescription pill or any other doxylamine product⁹.

Ask your provider before adding a supplement taken for sleep, such as melatonin or magnesium: the Unisom label says to check with a doctor or pharmacist first if you take sedatives or any other sleep aid⁹.

The prescription label also says¹⁴:

• Don't take it with a monoamine oxidase inhibitor (MAOI).
• Use it with caution if you have raised eye pressure or narrow-angle glaucoma, a narrowing (stenosing) peptic ulcer, a blockage where the stomach empties into the bowel, or a blocked bladder outlet.
• It can cause false-positive urine drug screens for methadone, opiates and PCP; a confirmatory test can settle a positive result.

Call your obstetric provider if you can't keep liquids down, pass only a small amount of dark urine or can't urinate, feel dizzy or faint when you stand up, or have a racing or pounding heartbeat: these are signs of dehydration¹. Losing weight because you can't keep food or fluids down also needs attention¹. Nausea and vomiting that start for the first time after 9 weeks, or come with abdominal pain, fever, headache or a swollen neck, can point to another cause, such as an ulcer, food-related illness, or thyroid or gallbladder disease¹.

Hyperemesis gravidarum affects up to 3% of pregnancies and is the severe end of the spectrum¹⁶; the prescription pill hasn't been studied in women who have it¹⁴. The UK guideline says ondansetron can be used as a second-line medicine if first-line drugs fail, and that women admitted with vomiting should receive thiamine¹². In a small trial of 36 women, 4 mg of ondansetron cut nausea scores more than 25 mg of B6 with 12.5 mg of doxylamine over 5 days (51 mm versus 20 mm on a 100 mm scale)¹¹.

Ondansetron has trade-offs of its own. The UK guideline notes a very small increase in the absolute risk of cleft lip or palate with first-trimester use, to be weighed against the risks of poorly controlled hyperemesis¹². ACOG's patient guidance says studies are not clear about its safety for the fetus, and that it has been linked to heart-rhythm problems¹. It's a prescription decision to make with your provider.

Ginger is a non-drug option. The Cochrane review found it may help but the evidence was limited and inconsistent¹⁹. See the ginger for nausea page and our guide to ginger and turmeric shots.

Supplements in this guide

• Vitamin B6 (Pyridoxine)
• Ginger

We searched PubMed and the Cochrane Library for trials, systematic reviews and guidelines on doxylamine, pyridoxine and nausea and vomiting of pregnancy, and read the NIH Office of Dietary Supplements B6 fact sheet, ACOG's patient guidance, and the DailyMed labels for the prescription pill and Unisom SleepTabs on 14 October 2026. We cited 17 journal records and 5 web pages. ACOG's full practice bulletin is behind a paywall, so the dosing here comes from the NIH fact sheet and a peer-reviewed review that reproduces ACOG's treatment steps. Trial data are short (3 to 14 days), so long-term use is not covered. This article doesn't cover interactions of Benadryl or Zyrtec with supplements outside pregnancy.

1. American College of Obstetricians and Gynecologists. Morning Sickness: Nausea and Vomiting of Pregnancy (patient FAQ). https://www.acog.org/womens-health/faqs/morning-sickness-nausea-and-vomiting-of-pregnancy
2. National Institutes of Health, Office of Dietary Supplements. Vitamin B6: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
3. Pharmacological Treatment of Insomnia (over-the-counter antihistamines section). PubMed Central PMC4634348. https://pmc.ncbi.nlm.nih.gov/articles/PMC4634348/
4. Nuangchamnong N, et al. Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview. Int J Womens Health. 2014;6:401-9. doi:10.2147/IJWH.S46653
5. Vutyavanich T, et al. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173(3 Pt 1):881-4. doi:10.1016/0002-9378(95)90359-3
6. Jayawardena R, et al. The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;308(4):1075-1084. doi:10.1007/s00404-023-06925-w
7. Persaud N, et al. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?. J Obstet Gynaecol Can. 2014;36(4):343-348. doi:10.1016/S1701-2163(15)30611-3
8. Pope E, et al. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study. J Clin Pharmacol. 2015;55(7):809-14. doi:10.1002/jcph.480
9. Unisom SleepTabs (doxylamine succinate 25 mg tablets): Drug Facts label. DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ae32d74-76a0-47e2-9e5c-812426413c4e
10. Koren G, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol. 2010;203(6):571.e1-7. doi:10.1016/j.ajog.2010.07.030
11. Oliveira LG, et al. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstet Gynecol. 2014;124(4):735-742. doi:10.1097/AOG.0000000000000479
12. Nelson-Piercy C, et al. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69). BJOG. 2024;131(7):e1-e30. doi:10.1111/1471-0528.17739
13. Sahakian V, et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991;78(1):33-6. https://pubmed.ncbi.nlm.nih.gov/2047064/
14. Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets: FDA prescribing information (revised June 2023). DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bde08f6-e8bd-4e90-baa7-82e01876a86a
15. Maltepe C, et al. Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial. Obstet Gynecol Int. 2013;2013:809787. doi:10.1155/2013/809787
16. McParlin C, et al. Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review. JAMA. 2016;316(13):1392-1401. doi:10.1001/jama.2016.14337
17. Persaud N, et al. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis. PLoS One. 2018;13(1):e0189978. doi:10.1371/journal.pone.0189978
18. Wu XK, et al. Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 × 2 Factorial Trial. Ann Intern Med. 2023;176(7):922-933. doi:10.7326/M22-2974
19. Matthews A, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;2015(9):CD007575. doi:10.1002/14651858.CD007575.pub4
20. Etwel F, et al. The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis. Drug Saf. 2017;40(2):121-132. doi:10.1007/s40264-016-0479-9
21. Bérard A, et al. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy. J Clin Epidemiol. 2019;116:39-48. doi:10.1016/j.jclinepi.2019.07.014
22. Biffi A, et al. Misleading meta-analyses of observational studies may generate unjustified alarms: The case of medications for nausea and vomiting in pregnancy. Pharmacol Res. 2021;163:105229. doi:10.1016/j.phrs.2020.105229